SCHEMBL22296481

SCHEMBL22296481

c1ccc(-c2nc(-c3cccc(-n4c5ccccc5c5ccccc54)c3)nc(-n3c4ccccc4c4ccccc43)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ ABCG2 Q9UNQ0 6/20 0.40
▸ KMT2A Q03164 4/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ GAA P10253 1/20 0.38
▸ IL1R1 P14778 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ PLA2G10 O15496 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HTT P42858 1/20 0.35
▸ ABCB1 P08183 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ FOLH1 Q04609 1/20 0.35
▸ ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22225008 0.97 KDM4E (0.47) L3MBTL1KDM4EATMABCG2KMT2A
SCHEMBL26710888 0.97 L3MBTL1 (0.47) L3MBTL1KDM4EATMABCG2KMT2A
SCHEMBL24609466 0.97 L3MBTL1 (0.48) L3MBTL1KDM4EATMABCG2KMT2A
SCHEMBL16674323 0.96 L3MBTL1 (0.46) L3MBTL1KDM4EATMABCG2KMT2A
SCHEMBL12455311 0.95 L3MBTL1 (0.55) L3MBTL1KDM4EATMABCG2KMT2A
SCHEMBL30516185 0.95 L3MBTL1 (0.55) L3MBTL1KDM4EATMABCG2KMT2A
SCHEMBL13010236 0.95 L3MBTL1 (0.55) L3MBTL1KDM4EATMABCG2KMT2A
SCHEMBL18593794 0.94 L3MBTL1 (0.49) L3MBTL1KDM4EATMABCG2KMT2A
SCHEMBL16689528 0.94 L3MBTL1 (0.45) L3MBTL1KDM4EATMABCG2KMT2A
SCHEMBL24677115 0.94 L3MBTL1 (0.45) L3MBTL1KDM4EATMABCG2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023434-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2024-01-18 — — US disclosed
EP-3689867-B1 COMPOSITION, ORGANIC SEMICONDUCTOR LAYER AND ELECTRONIC DEVICE NOVALED GMBH (DE) 2021-12-15 — — EP disclosed
WO-2020157204-A1 COMPOSITION, ORGANIC SEMICONDUCTOR LAYER AND ELECTRONIC DEVICE NOVALED GMBH (DE) 2020-08-06 — — WO disclosed
EP-3689867-A1 COMPOSITION, ORGANIC SEMICONDUCTOR LAYER AND ELECTRONIC DEVICE Novaled GmbH (DE) 2020-08-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023434-A1 ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD1, OCIAD2, AOX1 L3MBTL1 4235/4885KDM4E 4085/4885ATM 3335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback